Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme

Diabetic Medicine

Volumn 20, Issue 9, 2003, Pages 758-765

  Younis, N ^a   Broadbent, D M ^a   Harding, S P ^a   Vora, J P ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFIDENCE INTERVAL; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PROLIFERATIVE RETINOPATHY; RETINA MACULOPATHY; RETINOPATHY; SCREENING; ADULT; FEMALE; FOLLOW UP; INCIDENCE; MALE; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PHOTOGRAPHY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; UNITED KINGDOM; VISION TEST; VISUAL DISORDER;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DISEASE PROGRESSION; ENGLAND; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHOTOGRAPHY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; VISION DISORDERS; VISION SCREENING;

EID: 0642336163     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.01035.x     Document Type: Article

References (33)

1. Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 1995; 102: 647-661.
2. Moss SE, Klein R, Klein BE. The incidence of vision loss in a diabetic population. Ophthalmology 1988; 95: 1340-1348.
3. Grey RHB, Burns-Cox CJ, Hughes A. Blind partial sight registration in Avon. Br J Ophthalmol 1989; 73: 88-94.
4. Diabetic Retinopathy Study. Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Study report no. 5. Dev Ophthahnol 1981; 2: 248-261.
5. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Study report no. 1. Arch Ophthalmol 1985; 103: 1796-1806.
6. Klein R, Klein BE, Moss SE, DeMets DL. The validity of a survey question to study diabetic retinopathy. Am J Epidemiol 1986; 124: 104-110.
7. Klein R, Moss SE, Klein BE. New management concepts for timely diagnosis of diabetic retinopathy treatable by photocoagulation. Diabetes Care 1987; 10: 633-638.
8. Harding SP, Broadbent DM, Neoh C, White MC, Vora J. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study. Br Med J 1995; 311: 1131-1135.
9. Klein R, Klein BE, Neider MW, Hubbard LD, Meuer SM, Brothers RJ. Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology 1985; 92: 485-491.
10. James M, Turner DA, Broadbent DM, Vora J, Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. Br Med J 2000; 320: 1627-1631.
11. Sculpher MJ, Buxton MJ, Ferguson BA, Spiegelhalter DJ, Kirby AJ. Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies. Health Economics 1992; 1: 39-51.
12. Kohner EM, Porta M. Protocols for screening and treatment of diabetic retinopathy in Europe. Eur J Ophthalmol 1991; 1: 45-54.
13. American Diabetes Association. Diabetic retinopathy. Diabetes Care 1998; 21: 157-159.
14. Dwyer MS, Melton LJD, Ballard DJ, Palumbo PJ, Trautmann JC, Chu CP. Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota. Diabetes Care 1985; 8: 316-322.
15. Kristinsson JK, Hauksdóttir H, Stefánsson E, Jónasson F, Gislason I. Active prevention in diabetic eye disease. A 4-year follow-up. Acta Ophthalmol Scand 1997; 75: 249-254.
16. Nielsen NV. Diabetic retinopathy I. The course of retinopathy in insulin-treated diabetics. A one year cpidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmol (Copenh.) 1984; 62: 256-265.
17. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989; 107: 237-243.
18. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemilogic Study of Diabetic Retinopathy XV. The long-term incidence of macular edema. Ophthalmology 1995; 102: 7-16.
19. Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003; 361: 195-200.
20. Broadbent DM, Scott JA, Vora JP, Harding SP. Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study. Eye 1999; 13: 160-165.
21. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs -an extension of the modified Airlie House classification. ETDRS report no. 10. Ophthalmology 1991; 98: 786-806.
22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-458.
23. Broadbent DM, Harding SP, James M, Vora JP. Does stereoscopic macular photography improve the detection of macular oedema: a further sensitivity analysis. Diabet Med 2000; 17: S47.
24. von Wendt G, Heikkila K, Summanen P. Detection of retinal neovascularizations using 45 degrees and 60 degrees photographic fields with varying 45 degrees fields simulated on a 60 degrees photograph. Acta Ophthalmol Scand 2002; 80: 372-378.
25. Agardh E, Agardh CD, Torffvit O. A 5-year follow-up study on the incidence of retinopathy in type 1 diabetes mellitus in relation to medical risk indicators. J Intern Med 1994; 235: 353-358.
26. National Health and Medical Research Council Management of Diabetic Retinopathy. Clinical Practice Guidelines. Canberra: National Health and Medical Research Council, Australia, 1997.
27. Garvican L, Clowes J, Gillow T. Preservation of sight in diabetes: developing a national risk reduction programme. Diabet Med 2000; 17: 627-634.
28. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 520-526.
29. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemilogic study of Diabetic Retinopathy IV. Diabetic Macular Edema. Ophthalmology 1984; 91: 1464-1474.
30. Henricsson M, Sellman A, Tyrberg M, Groop L. Progression to proliferative retinopathy and macular oedema requiring treatment. Assessment of the alternative classification of the Wisconsin Study. Acta Oplithalmol Scand 1999; 77: 218-223.
31. Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XI. The incidence of macular edema. Ophthalmology 1989; 96: 1501-1510.
32. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994; 112: 1217-1228.
33. The Diabetic Retinopathy Study Research Group. Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. Arch Ophthalmol 1979; 97: 654-655.